Bruck Kifle

Array ( [id] => 6409884 [patent_doc_number] => 20020038023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Process for nylon depolymerization' [patent_app_type] => new [patent_app_number] => 09/983218 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4269 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20020038023.pdf [firstpage_image] =>[orig_patent_app_number] => 09983218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637198 [patent_doc_number] => 20020086871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Pharmaceutical composition for the treatment of CNS and other disorders' [patent_app_type] => new [patent_app_number] => 10/047850 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18947 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086871.pdf [firstpage_image] =>[orig_patent_app_number] => 10047850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1360105 [patent_doc_number] => 06573259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-03 [patent_title] => 'Inhibitors of interleukin-1 converting enzyme' [patent_app_type] => B2 [patent_app_number] => 10/035850 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16705 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573259.pdf [firstpage_image] =>[orig_patent_app_number] => 10035850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1425416 [patent_doc_number] => 06503903 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Fab I inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/959172 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11422 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 431 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503903.pdf [firstpage_image] =>[orig_patent_app_number] => 09959172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261757 [patent_doc_number] => 06664253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-16 [patent_title] => 'Neurokinin antagonists' [patent_app_type] => B2 [patent_app_number] => 09/978639 [patent_app_country] => US [patent_app_date] => 2001-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2697 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664253.pdf [firstpage_image] =>[orig_patent_app_number] => 09978639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1142220 [patent_doc_number] => 06777414 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-17 [patent_title] => 'Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same' [patent_app_type] => B1 [patent_app_number] => 09/958296 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80190 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 695 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777414.pdf [firstpage_image] =>[orig_patent_app_number] => 09958296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417874 [patent_doc_number] => 06509340 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-21 [patent_title] => 'Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligands' [patent_app_type] => B1 [patent_app_number] => 09/868840 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6089 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509340.pdf [firstpage_image] =>[orig_patent_app_number] => 09868840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1142426 [patent_doc_number] => 06777441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-17 [patent_title] => 'Triptolide analogs for the treatment of autoimmune and inflammatory disorders' [patent_app_type] => B2 [patent_app_number] => 09/970089 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 148366 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777441.pdf [firstpage_image] =>[orig_patent_app_number] => 09970089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1281724 [patent_doc_number] => 06642225 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-04 [patent_title] => 'Diazacycloalkanedione derivatives' [patent_app_type] => B2 [patent_app_number] => 09/968389 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6223 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 385 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642225.pdf [firstpage_image] =>[orig_patent_app_number] => 09968389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589925 [patent_doc_number] => 06482945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-19 [patent_title] => 'Process for producing epsilon-caprolactam and apparatus for the process' [patent_app_type] => B2 [patent_app_number] => 09/964424 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 6888 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482945.pdf [firstpage_image] =>[orig_patent_app_number] => 09964424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6362881 [patent_doc_number] => 20020058807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Process for preparation of N-1 protected N ring nitrogen containing cyclic polyamines and products thereof' [patent_app_type] => new [patent_app_number] => 09/970288 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6646 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058807.pdf [firstpage_image] =>[orig_patent_app_number] => 09970288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600688 [patent_doc_number] => 20020042509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Method for producing epsilon-caprolactam and reactor for the method' [patent_app_type] => new [patent_app_number] => 09/963603 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5816 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042509.pdf [firstpage_image] =>[orig_patent_app_number] => 09963603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985549 [patent_doc_number] => 06924277 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-02 [patent_title] => 'Cyclized benzamide neurokinin antagonists for use in therapy' [patent_app_type] => utility [patent_app_number] => 10/381755 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8490 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924277.pdf [firstpage_image] =>[orig_patent_app_number] => 10381755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1246283 [patent_doc_number] => 06677450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Topoisomerase inhibitors' [patent_app_type] => B2 [patent_app_number] => 09/965976 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12497 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677450.pdf [firstpage_image] =>[orig_patent_app_number] => 09965976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 425178 [patent_doc_number] => 07271160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases' [patent_app_type] => utility [patent_app_number] => 09/960665 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4301 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/271/07271160.pdf [firstpage_image] =>[orig_patent_app_number] => 09960665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1347659 [patent_doc_number] => 06583135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-24 [patent_title] => 'Substituted azepino4,5bindole derivatives' [patent_app_type] => B2 [patent_app_number] => 09/957625 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 71900 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583135.pdf [firstpage_image] =>[orig_patent_app_number] => 09957625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7623688 [patent_doc_number] => 06686477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-03 [patent_title] => 'Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same' [patent_app_type] => B2 [patent_app_number] => 09/957182 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8050 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/686/06686477.pdf [firstpage_image] =>[orig_patent_app_number] => 09957182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131444 [patent_doc_number] => 20020077318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Substituted azepino[4,5b] indoline derivatives' [patent_app_type] => new [patent_app_number] => 09/957319 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 92937 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077318.pdf [firstpage_image] =>[orig_patent_app_number] => 09957319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658152 [patent_doc_number] => 20030078256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Benzothiazine derivative' [patent_app_type] => new [patent_app_number] => 09/955416 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37382 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078256.pdf [firstpage_image] =>[orig_patent_app_number] => 09955416 [rel_patent_id] =>[rel_patent_doc_number] =>)